Raddatz, Rita et al
"CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities." Journal of Pharmacology and Experimental Therapeutics
340.1
(2012):
124-133.
Web. 02 June. 2023.
